Physician profile
Daniel B Buchalter
NPI 1306379144
$44,992.50
in general payments reported to CMS, 2019-2025
18 companies · $13K in 2025
The $13K reported for 2025 was more than what 78% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $11K · 2024: $22K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Food and Beverage: $6,784 · Travel and Lodging: $6,277 · Education: $5,833 · Grant: $5,833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,265.00 |
| Food and Beverage | $6,783.64 |
| Travel and Lodging | $6,277.20 |
| Education | $5,833.33 |
| Grant | $5,833.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $17,970.29 | 2023-2025 | Excelsius Gps, Legacy Stelkast Knee, A/R Femoral Nail |
| Smith+Nephew, INC. | $14,845.76 | 2023-2025 | Journey II, Legion Revision, Ri Hip Navigation |
| Medical Device Business Services, INC. | $5,497.75 | 2024-2025 | Actis, Velys, Attune |
| Stryker Corporation | $2,913.51 | 2023-2025 | Mako, Triathlon, Pangea |
| Depuy Synthes Sales INC. | $1,816.83 | 2023-2025 | Attune, Velys, Actis |
| Zimmer Biomet Holdings, INC. | $683.07 | 2023-2024 | Avenir, Mymobility Platform, Oss Orthopedic Salvage System |
| Ortho Development Corporation | $285.93 | 2023-2025 | |
| Davol INC. | $159.91 | 2023 | |
| Orthalign INC | $139.96 | 2023 | Orthalign Plus |
| Djo, LLC | $124.58 | 2025 | Cmf |
| Arthrex, INC. | $120.51 | 2025 | |
| Heraeus Medical, LLC. | $111.00 | 2023 | Palacos |
| Providence Medical Technology, INC. | $80.54 | 2024 | |
| Ethicon US, LLC | $77.40 | 2025 | Dermabond |
| Linvatec Corporation | $56.77 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linkbio Corp | $51.84 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $40.70 | 2025 | Iovera, Zilretta |
| Gotham Surgical Solutions & Devices, INC. | $16.15 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Buchalter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.